WASHINGTON — Vinay Prasad is returning to the Meals and Drug Administration to renew his position overseeing vaccine, gene remedy, and blood product regulation.
“On the FDA’s request, Dr. Vinay Prasad is resuming management of the Middle for Biologics Analysis and Analysis,” Well being and Human Providers spokesman Andrew Nixon informed STAT on Saturday.
It’s not clear whether or not Prasad may even nonetheless function the FDA’s chief medical and scientific officer. He left the company a mere two weeks in the past, amid escalating tensions associated to a gene remedy product for Duchenne’s muscular dystrophy made by Sarepta Therapeutics and a marketing campaign launched by right-wing influencer Laura Loomer, during which she criticized Prasad’s earlier posts describing himself as liberal.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences business — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
